Sphera Funds Management Ltd. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $380 Million distributed in 116 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $24.2M, Syndax Pharmaceuticals Inc with a value of $20.5M, Sanofi with a value of $16.9M, Nova Ltd. with a value of $16.7M, and Astrazeneca PLC with a value of $12.9M.

Examining the 13F form we can see an decrease of $106M in the current position value, from $486M to 380M.

Sphera Funds Management Ltd. is based out at Tel Aviv, L3

Below you can find more details about Sphera Funds Management Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $380 Million
Healthcare: $276 Million
Technology: $54.9 Million
ETFs: $23.2 Million
Consumer Cyclical: $8.87 Million
Communication Services: $7.85 Million
Utilities: $5.94 Million
Basic Materials: $1.53 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 116
  • Current Value $380 Million
  • Prior Value $486 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 18 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 51 stocks
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.